China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at

Investment analysts at assumed coverage on shares of China Pharma (NYSE:CPHIGet Rating) in a report issued on Monday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of NYSE:CPHI opened at $0.21 on Monday. The company has a 50-day simple moving average of $0.22. China Pharma has a one year low of $0.19 and a one year high of $0.97. The company has a quick ratio of 0.43, a current ratio of 0.82 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $10.22 million, a PE ratio of -2.65 and a beta of 0.50.

China Pharma (NYSE:CPHIGet Rating) last posted its quarterly earnings results on Thursday, May 12th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $1.60 million for the quarter. China Pharma had a negative return on equity of 59.21% and a negative net margin of 41.21%.

China Pharma Company Profile

(Get Rating)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Read More

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with's FREE daily email newsletter.